Stemline Therapeutics News - STML

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Stemline Therapeutics Inc STML NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.27 -3.8% 6.83 6.81 7.11 7.06 7.10 00:00:00
more quote information »

Recent News

Date Time Source Heading
2/18/202006:11EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202008:54EDGARStatement of Ownership (sc 13g)
2/12/202016:13EDGARAmended Statement of Ownership (sc 13g/a)
2/12/202012:58EDGARStatement of Ownership (sc 13g)
2/06/202009:17EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202015:37EDGARStatement of Ownership (sc 13g)
1/13/202016:15GLOBEStemline Therapeutics Announces Preliminary 2019 Net..
1/08/202016:15GLOBEStemline Therapeutics to Present at the 38th Annual J.P...
1/03/202017:20EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202017:19EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202017:19EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202017:18EDGARStatement of Changes in Beneficial Ownership (4)
12/23/201917:11EDGARInitial Statement of Beneficial Ownership (3)
12/10/201908:00GLOBEStemline Therapeutics Recaps ELZONRIS Clinical Data..
12/06/201918:30GLOBEStemline Therapeutics Names Robert M. Francomano Chief..
12/06/201907:00GLOBEStemline Therapeutics Highlights Three ELZONRIS..
11/29/201913:05GLOBEStemline Therapeutics to Present at Piper Jaffray’s 31st..
11/12/201916:35EDGARQuarterly Report (10-q)
11/07/201917:30EDGARCurrent Report Filing (8-k)
11/07/201916:57GLOBEStemline Therapeutics Reports Third Quarter 2019 Financial..
11/06/201909:15GLOBEStemline Therapeutics Announces Three ELZONRIS..
11/05/201916:22GLOBEStemline Therapeutics to Host Conference Call on Third..
10/08/201907:30GLOBEStemline Therapeutics Announces ELZONRIS® Clinical Data..
10/01/201907:30GLOBEStemline Therapeutics Recaps Felezonexor (SL-801) Clinical..
9/27/201907:30GLOBEStemline Therapeutics Announces Felezonexor (SL-801)..
9/26/201916:01GLOBEStemline Therapeutics to Present at the 2019 Cantor Global..
9/18/201909:32GLOBEStemline Therapeutics to Present at the Ladenburg Thalmann..
9/05/201907:30GLOBEStemline Therapeutics to Present at the H.C. Wainwright 21st..
8/09/201916:00GLOBEStemline Therapeutics to Present at the 2019 Wedbush PacGrow..
8/09/201913:18EDGARCurrent Report Filing (8-k)
8/09/201913:16EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/08/201922:23GLOBEStemline Therapeutics Announces Pricing of $76,250,000..
8/08/201906:10EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/07/201916:25GLOBEStemline Therapeutics Announces Proposed Public Offering of..
8/06/201916:37EDGARQuarterly Report (10-q)
8/06/201907:30GLOBEStemline Therapeutics Announces that CMS Grants New..
8/02/201907:31EDGARCurrent Report Filing (8-k)
8/02/201907:00GLOBEStemline Therapeutics Reports Second Quarter 2019 Financial..
7/29/201907:00GLOBEStemline Therapeutics to Host Conference Call on Second..
7/08/201917:50GLOBEStemline Therapeutics Highlights Recent Clinical and..
6/28/201917:18EDGARStatement of Changes in Beneficial Ownership (4)
6/28/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
6/28/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
6/28/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
6/28/201917:16EDGARStatement of Changes in Beneficial Ownership (4)
6/28/201917:16EDGARStatement of Changes in Beneficial Ownership (4)
6/28/201917:16EDGARStatement of Changes in Beneficial Ownership (4)
6/28/201917:15EDGARStatement of Changes in Beneficial Ownership (4)
6/28/201917:11EDGARSecurities Registration: Employee Benefit Plan (s-8)
6/28/201916:32EDGARCurrent Report Filing (8-k)
See more news about this stock »


Your Recent History
NASDAQ
STML
Stemline T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.